List view / Grid view
19 October 2016 | By Niamh Louise Marriott, Digital Content Producer
Non-inferiority was demonstrated in a Phase 3 trial for the co-primary endpoints of ongoing pregnancy rate and ongoing implantation rate for Rekovelle...
20 September 2016 | By Ernest Loumaye, MD, PhD, Co-Founder & Chief Executive Officer, ObsEva
Ernest Loumaye, PhD, Co-Founder & Chief Executive Officer of ObsEva discusses the unmet need of women's reproductive health and what's in the pipeline for treatment...
8 September 2016 | By Niamh Louise Marriott, Digital Content Producer
The coil is the most effective form of emergency contraception for up to 5 days after unprotected sex or within 5 days of expected ovulation...
10 March 2016 | By Victoria White
Teva is to support IVF-Worldwide with a research grant to improve knowledge of fertility preservation protocols for women diagnosed with cancer...
18 June 2015 | By Victoria White
Merck Serono has announced its strong support of the Grant for Fertility Innovation (GFI) fund with grants totalling up to € 1.2 million for 2015 / 2016...
11 June 2015 | By Victoria White
Merck Serono has announced that the product design of its fertility pens won over the 38-member jury of the Red Dot Award: Product Design 2015...
11 June 2015 | By Victoria White
The results of a study presented at EULAR 2015 show that NSAIDs, such as diclofenac, significantly inhibit ovulation in women with mild musculoskeletal pain...
10 December 2014 | By Roche
New data demonstrate high prognostic value of Elecsys blood test...
9 September 2013 | By Merck
Merck announced that the NDA for its investigational fertility treatment, corifollitropin alfa, has been accepted for standard review by the U.S. FDA...
23 October 2012 | By Merck
New Phase III study presented...
